Why Improve Our Knowledge and Clinical Practice in the Management of Patients With Coronary Vasospasm?

Affiliations

¹ Université de Paris, Assistance Publique - Hôpitaux de Paris, Hôtel Dieu, Centre de Diagnostic et de Thérapeutique, Paris, France; FACT (French Alliance for Cardiovascular Trials) Network, Paris, France; INSERM U-1148, Laboratory for Vascular Translational Science, Paris, France. Electronic address: emmanuel.sorbets@aphp.fr.
² Université de Paris, Assistance Publique - Hôpitaux de Paris, Hôtel Dieu, Centre de Diagnostic et de Thérapeutique, Paris, France.

Free article

Editorial

Emmanuel Sorbets et al. JACC Cardiovasc Interv. 2020.

Free article

. 2020 Aug 24;13(16):1877-1879.

doi: 10.1016/j.jcin.2020.06.044. Epub 2020 Jul 29.

¹ Université de Paris, Assistance Publique - Hôpitaux de Paris, Hôtel Dieu, Centre de Diagnostic et de Thérapeutique, Paris, France; FACT (French Alliance for Cardiovascular Trials) Network, Paris, France; INSERM U-1148, Laboratory for Vascular Translational Science, Paris, France. Electronic address: emmanuel.sorbets@aphp.fr.
² Université de Paris, Assistance Publique - Hôpitaux de Paris, Hôtel Dieu, Centre de Diagnostic et de Thérapeutique, Paris, France.

No abstract available

Keywords: acetylcholine; angina; coronary vasospasm; prognosis.

Comment on

Long-Term Follow-Up in Patients With Stable Angina and Unobstructed Coronary Arteries Undergoing Intracoronary Acetylcholine Testing.
Seitz A, Gardezy J, Pirozzolo G, Probst S, Athanasiadis A, Hill S, Mahrholdt H, Bekeredjian R, Sechtem U, Ong P. Seitz A, et al. JACC Cardiovasc Interv. 2020 Aug 24;13(16):1865-1876. doi: 10.1016/j.jcin.2020.05.009. Epub 2020 Jul 29. JACC Cardiovasc Interv. 2020. PMID: 32739303